Khi sức mạnh tính toán của AI cũng bắt đầu được "chia sẻ", ai sẽ trở thành người dẫn đầu trong cuộc cạnh tranh mới này?

Litmore Capital

investment firm

About

Litmore Capital

Details

Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
2
0
Litmore Capital has made 2 investments. Their most recent investment was on Feb 21, 2017, when Bristol Myers Squibb raised $80M.
Date Company Name
Round Money Raised Industry Lead Investor
Post-IPO Equity $80M Biotechnology
Series Unknown $80M Biotechnology

Exits

Litmore Capital has had 2 exits. Litmore Capital most notable exits include Biohaven Pharmaceutical ,   Bristol Myers Squibb

Date Company Name Exit Type Industry
May 5, 2017 Biohaven Pharmaceutical M&A Biotechnology Detail
Jan 1, 1972 Bristol Myers Squibb IPO Biotechnology Detail